🔎 Trials Near Me

Home › Prostate Cancer › Rhode Island › Providence

Prostate Cancer clinical trials in Providence, RI

7 studies for Prostate Cancer are looking for participants at sites in and around Providence (within about 30 miles). Open a study to see who can join and how to contact the study team.

Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer

RecruitingPhase 1/2
  • Research Site, Providence
Ages 18 to 130 · Men · Updated Sep 25, 2026 · NCT07181161

A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation

RecruitingPhase 3
  • Research Site, Providence
Ages 18 and older · Men · Updated Sep 18, 2026 · NCT06952803

First-in-Human Study to Evaluate AZD8359 STEAP2 TCE in Participants With Prostate Cancer

RecruitingPhase 1/2
  • Research Site, Providence
Ages 18 to 100 · Men · Updated Sep 9, 2026 · NCT07529717

Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)

RecruitingPhase 1
  • Rhode Island Hospital, Providence
Ages 18 to 100 · Men · Updated Aug 13, 2026 · NCT05519449

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

RecruitingPhase 3
  • Rhode Island Hospital, Providence
Ages 18 and older · Men · Updated Jul 14, 2026 · NCT06592924

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

RecruitingObservational study
  • Massive Bio SYNERGY-AI site, Providence
All ages · All sexes · Updated Oct 28, 2025 · NCT03452774

About Prostate Cancer

Prostate cancer is one of the most common types of cancer among American men. The risk goes up as men age. Learn about symptoms, tests, and treatment.

More about Prostate Cancer on MedlinePlus

Prostate Cancer trials in other cities

Other studies in Providence

From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.